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Abstract 
Physiological autophagy plays a crucial role in the regulation of muscle mass and metabolism, 
while the excessive induction or the inhibition of the autophagic flux contributes to the 
progression of several diseases. Autophagy can be activated by different stimuli, including 
cancer, exercise, caloric restriction and denervation. The latter leads to muscle atrophy through 
the activation of catabolic pathways, i.e. the ubiquitin-proteasome system and autophagy. 
However, the kinetics of autophagy activation and the upstream molecular pathways in 
denervated skeletal muscle have not been reported yet. In this study, we characterized the 
kinetics of autophagic induction, quickly triggered by denervation, and report the Akt/mTOR 
axis activation. Besides, with the aim to assess the relative contribution of autophagy in 
neurogenic muscle atrophy, we triggered autophagy with different stimuli along with 
denervation, and observed that four week-long autophagic induction, by either intermitted 
fasting or rapamycin treatment, did not significantly affect muscle mass loss. We conclude that: 
i) autophagy does not play a major role in inducing muscle loss following denervation; ii) 
nonetheless, autophagy may have a regulatory role in denervation induced muscle atrophy, since 
it is significantly upregulated as early as eight hours after denervation; iii) Akt/mTOR axis, 
AMPK and FoxO3a are activated consistently with the progression of muscle atrophy, further 
highlighting the complexity of the signaling response to the atrophying stimulus deriving from 
denervation.  
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 Macroautophagy, or simply autophagy, is a catabolic 
pathway that leads to the degradation of damaged or 
misfolded cytoplasmic proteins or organelles, via double-
membranes structures, the autophagosomes.1 More than 
30 autophagy-related (Atg) genes have been identified in 
yeast, and many of these are conserved among higher 
eukaryotes.2 Upon autophagy induction, cytosolic Atg8 / 
LC3b I, is conjugated to phosphatidylethanolamine, 
therefore converted to LC3b II (changing its apparent 
molecular weight from about 16 kDa to about 14 kDa) 
and incorporated into the autophagic membranes. 
Another important player in autophagy is p62, a 
chaperone protein that directs polyubiquitinated proteins 
to the autophagosomes, by directly binding to LC3b and 
Gabarapl1 proteins and allowing the degradation of 
protein aggregates via autophagy.3 The p62 protein is 
itself incorporated and degraded during autophagy, 
therefore it is often used as a marker for the progression 
of the autophagic flux.4 Although autophagy was long 
considered a non-selective degradation pathway, in the 
last years autophagy emerged as responsible for 
specifically removing only selected cellular components. 
Examples of selective autophagy include aggrephagy, to 
remove protein aggregates,5 pexophagy, for 
peroxisomes,6 or ribophagy, to eliminate ribosomes.7 
Mitophagy is an essential cellular mechanism controlling 
mitochondrial quality since its inhibition leads to 
accumulation of damaged or dysfunctional 
mitochondria.8 Deficiencies in mitophagy correlate with 
several pathologies, including neurodegenerative 
disorders such as Parkinson’s disease.9 Different cellular 
stimuli trigger autophagy, including cancer, ageing, 
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starvation, exercise, disuse and denervation.10–14 Two 
kinases, namely Akt and AMP-activated protein kinase 
(AMPK), modulate autophagy. Akt is a serine/threonine 
protein kinase that mediates cellular response to insulin, 
thereby contributing to energy metabolism, inducing 
protein synthesis and muscle hypertrophy. Consistently, 
Akt overexpression in adult skeletal muscle counteracts 
muscle atrophy induced by denervation.15 Indeed, 
activated phosphorylated Akt blocks atrophy by 
phosphorylating and thereby inactivating the 
transcription factor FoxO3a.16 The phosphorylated form 
of FoxO3a is excluded from the nucleus and therefore 
unable to activate the muscle-specific E3 ubiquitin 
ligases atrogin-1 and MuRF1.13 On the contrary, when 
Akt is dephosphorylated, such as upon starvation, it 
promotes the inhibition of the mammalian target of 
rapamycin (mTOR), a potent autophagy suppressor, 17 
and the activation of FoxO3a, a major inducer of 
autophagy- and proteasome-mediated catabolism, by its 
dephosphorylation and consequent translocation into the 
nucleus.13 In response to low levels of cellular energy, 
also AMPK is activated and induces autophagy by 
modulating the same Akt molecular targets, i.e. mTOR 
and FoxO3a.18–20 However, while Akt phosphorylates 
FoxO3a on thr32, ser253 and ser315, AMPK targets 
Foxo3 on different residues, phosphorylating ser413 and 
ser588.21  Autophagy has long been regarded as a cellular 
process leading to muscle wasting and atrophy in several 
muscular diseases, such as myopathies, dystrophies or 
neurogenerative disorders.22,23 However, a role for basal, 
physiological levels of autophagy in the maintenance of 
muscle mass and homeostasis has been assessed. Indeed, 
mouse models lacking Atg5 or Atg7 in skeletal muscle, 
or with compromised autophagy, such as the mutant mice 
for the histone deacetylase 1 and 2,24 show muscle loss, 
intracellular protein aggregates, and accumulation of 
abnormal membranous structures. Interestingly, the 
absence of Atg7 in skeletal muscle does not preserve 
muscle mass during catabolic conditions and, 
surprisingly, exacerbates muscle loss upon denervation.25 
Despite the activation of autophagic markers has been 
reported three days following denervation in skeletal 
muscle,26 a fine characterization of the kinetics of 
autophagy activation upon denervation is still missing. 
The present study aims to better clarify the kinetics of 
autophagy activation and the upstream molecular 
pathways in murine skeletal muscle following 
denervation, and to assess the contribution of autophagy 
to neurogenic muscle atrophy in vivo. 
Materials and Methods 
Animal models and Ethical Approval 
Mice were treated in strict accordance with the guidelines 
of the Institutional Animal Care and Use Committee and 
to national and European legislation, throughout the 
experiments. All the experimental protocols were 
approved by the Charles Darwin Ethics Committee n°5 
in Paris and by the Ministry of Research. Adult (2.5-
month-old) C57BL/6 female mice were used throughout 
the experiments.  
Denervation. The sciatic nerve of the left limb of 
anesthetized adult female C57/BL6 mice was cut and a 3 
mm piece was excised. The right leg remained innervated 
and was used as control. Mice were sacrificed at 
indicated time points for histological and molecular 
analyses.  
Intermittent fasting. In intermittent fasting (IF) 
experiments, the chow was removed from the cages of 4 
mice, for 24 hours, twice a week, for 4 weeks, starting 
from the day of denervation, to evaluate the effects on 
both innervated and denervated muscles. 
Rapamycin injections. Daily injections of 2 mg/kg 
rapamycin in physiologic solution containing 1% ethanol 
(vehicle), or of vehicle, were performed for 4 weeks from 
the day of denervation, in 4 mice for each condition, to 
evaluate the effects on both innervated and denervated 
muscles. 
Histological Analyses 
Tibialis Anterior (TA) muscles were dissected, 
embedded in tissue freezing medium (Leica, Wetzlar, 
Germany) and frozen in liquid nitrogen pre-cooled 
isopentane. Cryosections (8 μm) were obtained by using 
a Leica cryostat. Hematoxylin and eosin staining (Sigma-
Aldrich) was performed according to the manufacturer’s 
instructions. 
RNA Extraction and Real-time PCR 
Total RNA was isolated and purified from 30-50 mg of 
TA muscles by using Trizol (Invitrogen), following the 
manufacturer's protocol. One microgram of total RNA 
was converted to cDNA by using the PrimeScript™ RT 
reagent Kit (TAKARA). Real-time PCR was performed 
with the SDS-ABI Prism 7500 (Applied Biosystem), by 
using the SYBR Green reaction mix (Applied 
Biosystem). The primer sequences used are reported 
below: 
Atg5 for: GGAGAGAAGAGGAGCCAGGT 
Atg5 rev: GCTGGGGGACAATGCTAATA 
Atg7 for: GCCTAACACAGATGCTGCAA 
Atg7 rev: TGCTCTTAAACCGAGGCTGT 
Gaparapl1 for: GTGCCGGTCATCGTGGA 
Gabarapl1 rev: TCCTCGTGGTTGTCCTCA 
LC3b for: CACTGCTCTGTCTTGTGTAGGTG  
LC3b rev: TCGTTGTGCCTTTATTATTAGTGCATC 
p62 for: CCCAGTGTCTTGGCATTCTT  
p62 rev: AGGGAAAGCAGAGGAAGCTC 
GAPDH for: ACCCAGAAGACTGTGGATGG 
GAPDH rev: CACATTGGGGGTAGGAACA 
Protein Extraction and Western Blot Analyses 
TA muscles were dissected, minced, and homogenized in 
lysis buffer (50 mM Tris-HCl pH 7.4, 1 mM EDTA, 150 
Mm NaCl, 1% TRITON) supplemented with protease 
and phosphatase inhibitors (Sigma-Aldrich). Proteins 
(30-50 micrograms) were separated by SDS-PAGE and 
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transferred to PVDF membrane (Invitrogen). Unspecific 
binding was blocked in 5% not fat dry milk in TBST 
buffer (20 mM Tris HCl pH 7.6, 137 mM NaCl, 0.5% 
Tween 20), then the membranes were incubated 
overnight with the primary antibody diluted in 5% BSA 
(Sigma) in TBST. After washing in TBST, the 
membranes were incubated with the secondary HRP-
conjugate antibodies (Bio-rad 170-6515 or 170-6516) 
and signals were detected by using ECL chemistry 
(Advansta). Images were acquired using the ChemiDoc 
MP imaging system (Bio-Rad). Densitometric analyses 
were performed by measuring the band intensity for each 
sample using the Image J software.  The following 
primary antibodies were used: GAPDH (Santa Cruz sc-
32233), P-AMPK (Cell Signaling 2535), AMPK (Cell 
Signaling 2532), P-ACC (Cell Signaling 3661), P-Akt 
(Cell Signaling 9271), Akt (Cell Signaling 9272), P-
FoxO3a (Ser253) (Cell Signaling 9466), Foxo3a (Cell 
Signaling 2497), P-mTOR (Ser2448) (Cell Signaling 
2971), mTOR (Cell Signaling 2983), LC3b (Cell 
Signaling 2775), p62 (Sigma-Aldrich P0067). 
Statistics 
Statistical significance was determined using two-tailed 
Student t-test with a significance level < 0.05 or by using 
two-way analysis of variance (ANOVA), followed by 
Tukey’s HSD as a post-hoc test, when more than two 
conditions needed to be compared. All values are 
expressed as mean ± standard error of the mean (SEM). 
VassarStats, a statistical computation website available at 
http://vassarstats.net/, was used for the statistical 
analyses. 
Results 
Autophagy is induced in skeletal muscle one day 
following denervation  
Aiming to investigate the kinetics of denervation-induced 
autophagy in skeletal muscle, we resected the sciatic 
nerve of one limb of adult mice and analyzed the target 
skeletal muscle over time. We used the contralateral 
muscle as control, since we had previously established 
that these muscles are unaffected by denervation.27 The 
expression levels of several autophagic genes were 
monitored by real-time PCR, following denervation (Fig. 
1A). The expression of some autophagy related genes, 
such as Atg5, LC3b and p62, was up-regulated as soon as 
eight hours upon denervation and increased over time, 
reaching statistical significance within eight to twenty-
four hours; while the expression of others, such as Atg7 
and Gabarapl1 significantly increased only from day 
three following denervation. Noticeably, LC3b 
expression showed a different, specific pattern, reaching 
its maximal induction one day following denervation and 
then decreasing, while still remaining significantly 
higher than control muscles (Fig. 1A). To further confirm 
these findings, we analyzed the lipidation of LC3b and 
the accumulation of p62 protein at one, three and seven 
days following denervation (Fig. 1B). Denervation 
induced a significant accumulation of the lipidated form 
 
Fig 1. Autophagy is quickly induced in skeletal muscle in response to denervation. (A) Real-time PCR for autophagic 
markers in skeletal muscle following denervation at indicated time points, relative to control (C) muscles. 
Values represent mean ± SEM. n=4-6 mice for each condition; *p<0.05; **p<0.001; ***p<0.0001 by 
Student’s t test vs control muscles. (B) Western blotting analyses and quantification for LC3b and p62 
proteins, one, three and seven days following denervation. GAPDH was used as loading control. Values 
represent mean ± SEM. n=4 mice for each condition; *p<0.05 by Student’s t test vs control muscles. 
No
 co
mm
erc
ial
 us
e o
nly
Autophagy and neurogenic muscle atrophy 
Eur J Transl Myol 28 (3): 248-256, 2018 
- 251 - 
 
of LC3b and p62 after 7 days, indicative of effective 
autophagosome formation upon denervation in skeletal 
muscle. 
Autophagy is associated with activation of both Akt- and 
AMPK- dependent pathways  
To elucidate the signaling pathways involved in 
autophagy, we quantified the expression and the 
activation of specific up-stream proteins controlling 
autophagy, one three and seven days following 
denervation. Increased levels of activated phospho (P)-
AMPK, but not total AMPK, were detected seven days 
following denervation, in respect to control muscles. 
Consistently, higher levels of phospho-acetyl-CoA 
Carboxylase, a direct target of AMPK,28 were observed 
seven days after denervation, compared to control 
muscles, indicative of AMPK activation (Fig. 2A). 
Moreover, both P-Akt and total Akt were significantly 
increased seven days following denervation, as well as P-
mTOR and total mTOR, indicative of Akt activation (Fig. 
2B). In addition, an important downregulation of P-
FoxO3 was detected three days following denervation, 
indicative of a nuclear localization and activation of this 
transcription factor (Fig. 2C). 
Autophagy does not contribute to muscle atrophy 
following denervation  
To investigate the contribution of autophagy to 
neurogenic muscle atrophy, we triggered autophagy in 
skeletal muscle from the day of denervation to day 28 
following denervation, by using two different 
approaches: a metabolic stimulus, i.e. intermittent fasting 
(IF) 14 and daily injections of the known autophagy 
activator, rapamycin (Rapa).10 We first verified that IF 
effectively activated autophagy in skeletal muscle 
following denervation, by confirming the significant 
accumulation of the lipidated form of LC3b and of p62, 
by western blot analyses (Fig. 3). Muscle mass evaluation 
and histological analyses revealed that neither IF, nor 
Rapa induce muscle atrophy in control muscles, or 
exacerbated muscle fiber atrophy in denervated muscles, 
despite increased autophagy for up to four weeks 
 
Fig 2. Up-stream activators of the autophagic pathway are activated upon denervation. (A) Western blotting 
analyses and quantification of P-AMPK, AMPK and P-ACC proteins, at indicated time points following 
denervation. GAPDH was used as control. Values represent mean ± SEM; n=4 mice for each condition; 
*p<0.05 by Student’s t test vs control (Ctr) muscles. (B) Western blotting analyses and quantification of 
Akt/mTOR pathway, at indicated time points following denervation. GAPDH was used as loading control. 
Values represent mean ± SEM. n=4 mice for each condition; *p<0.05 by Student’s t test vs Ctr muscles. c 
Western blotting analyses and quantification of P-FoxO3 and FoxO3 proteins, at indicated time points 
following denervation. GAPDH was used as loading control. Values represent mean ± SEM. n=4 mice for 
each condition; *p<0.05 by Student’s t test vs Ctr muscles. 
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following denervation (Fig. 4A and 4B). Morphometric 
analysis, i.e. fiber cross-sectional area distribution, 
confirmed these results. Indeed, while denervation 
significantly affected myofiber CSA, in the 500-1500, 
1000-1500, and >2500 μm2 classes, IF or Rapa did not 
significantly change myofiber CSA distribution of 
control or denervated muscles (Fig. 4C and D). These 
results clearly indicate that, despite the activation of 
autophagy following denervation, further activation of 
this pathway does not exacerbate neurogenic muscle 
atrophy, nor induce muscle atrophy in control muscles.  
Discussion 
Autophagy is a physiological process necessary to 
deliver dysfunctional organelles and proteins to 
lysosomes for degradation. Increased autophagy has long 
been considered as a harmful cellular process, which 
contributes to muscle wasting in several muscle diseases, 
such as myopathies, dystrophies or neurodegenerative 
disorders.22,23,29 Consistently, chronic activation of 
autophagy leads to muscle wasting.13,30 However, 
inhibition of autophagy is detrimental to skeletal muscle 
mass and architecture, indicating its essential 
physiological role in preserving muscle homeostasis.25,31 
The relevance of autophagy for skeletal muscle 
homeostasis was also recently demonstrated by our 
study, showing that the autophagic flux is overloaded in 
skeletal muscles of colon carcinoma patients and mice 
and that aerobic exercise or pharmacological treatments 
that promote autophagy rescue muscle homeostasis in 
tumor-bearing mice.10 Given the importance for muscle 
homeostasis of the dynamic balance between autophagy 
hyper-activation and inhibition, it is important to shed 
light on the activation of autophagy and the molecular 
pathways involved in its regulation in pathological 
settings, such as denervation. To date, several studies 
characterized skeletal muscle response to 
denervation,27,32,33 but conflicting results have been 
published on autophagy induction. Some studies reported 
that autophagy is triggered seven days after denervation, 
prevalently targeting mitochondria for their removal,34,35 
while according to others autophagy is rather suppressed 
in denervated muscles.36 None of the studies investigated 
earlier time points following denervation. Here, for the 
first time, we reported a significant increase in the 
expression levels of the autophagic markers LC3b and 
p62, as soon as eight hours following denervation. Being 
FoxO3a activated only three days following denervation, 
either other factors trigger the transcription of these 
autophagic genes, such as E2F1 or TFEB,37,38 or FoxO 
factors are transiently activated earlier than one day 
following denervation. The molecular pathways 
controlling autophagic induction in skeletal muscle upon 
denervation have been only partially elucidated and 
contradictory explanations have been reported. We 
observed that both the total and phosphorylated forms of 
Akt and mTOR were higher in denervated muscles after 
seven days, compared to control muscles, in agreement 
with what previously reported by others.39,40 Akt is a 
crucial regulator of muscle growth and hypertrophy, also 
preventing muscle atrophy.41,42 The activation of the Akt 
pathway following denervation, therefore, could 
represent an attempt to counteract muscle atrophy, by 
promoting muscle growth36 which may explain the 
persistence of muscle regeneration in long term 
denervated condition.32 Alternatively, the denervation-
induced increase mTOR activity may produce a feedback 
inhibition of Akt pathway43, or even contributes to 
increase proteasome levels.44 According to others, 
however, neurogenic muscle atrophy is independent of 
Akt and mTOR activation,45 supporting the hypothesis 
that other signals trigger the ubiquitin-proteasome 
pathway. Since mTOR inhibits autophagy,17 we propose 
that mTOR activation has no major effects on autophagy 
regulation upon denervation, differently from muscle 
atrophy induced by other stimuli.46 AMPK is an 
important mediator of skeletal muscle metabolism47 and 
is one of the kinases known to regulate autophagy, 
 
Fig 3. Intermittent fasting activates autophagy in skeletal muscle. Western blotting analyses and quantification of 
LC3b and p62 proteins in mice subjected (IF) or not (-) to intermittent fasting, seven days following 
denervation. GAPDH was used as loading control. Values represent mean ± SEM. n=4 mice for each 
condition; two-way ANOVA revealed an interaction between treatments (F=5.52; df 1; p=0.036 for LC3 and 
F=6.93; df 1; p=0.025 for p62); *p<0.05 vs untreated Ctr, by Tukey’s HSD test. 
No
n c
mm
erc
ial
 us
e o
nly
Autophagy and neurogenic muscle atrophy 
Eur J Transl Myol 28 (3): 248-256, 2018 
- 253 - 
 
together with Akt, by inhibiting mTOR and by activating 
FoxO3a.18,20 We found that P-AMPK and its downstream 
target ACC are accumulated in denervated muscles, one 
week following denervation, in respect to the control 
muscles. We reported a decrease in P-FoxO3a, three days 
after denervation, implying its transcriptional activation 
at early time points following denervation. Therefore, our 
data support the model that neither Akt, nor AMPK are 
responsible for the FoxO3a transcriptional activation at 
this early time point. Other kinases known to regulate the 
phosphorylation status of FoxO3a, such as P38 or 
JUNK,48,49 may be involved in this early response to 
denervation.  
To investigate the contribution of autophagy to muscle 
trophism, we induced autophagy in skeletal muscle 
following denervation by using two different approaches: 
IF and rapamycin. Importantly, the effects of IF on LC3b 
and p62 accumulation are independent of denervation, 
and the two stimuli seem to be additive. These data 
indicate that denervation does not induce a maximal 
activation of autophagy in skeletal muscle, but additional 
stimuli can further increase this process. Muscle atrophy 
was evaluated four weeks following denervation, a time 
point chosen to evaluate the effects on both innervated 
and denervated muscles. Muscle mass, histological and 
morphometrical analyses proved that both treatments did 
 
Fig 4. Autophagy does not contribute to muscle atrophy. (A) TA muscle weight of mice subjected to IF or treated 
with rapamycin (Rapa), or untreated (-), 28 days following denervation, relative to untreated control (Ctr) 
TA muscles. Values represent mean ± SEM. n=4 mice for each condition; two-way ANOVA revealed an effect 
of denervation (F=73 df 1; p=0.0001 for IF and F=98; df 1; p=0.0001 for Rapa), without interaction between 
treatments. (B) Representative pictures of the histology of treated (IF and Rapa) or not (-), control and 
denervated TA muscles, 28 days following denervation. Scale bar=50 micron. (C) Myofiber cross-sectional 
area distribution of TA muscles of mice without (-) or after IF treatment, four weeks after denervation. Data 
are shown as mean ± SEM; n=4 mice per each condition. Two-way ANOVA revealed an effect of denervation 
in the 500-1500, 1000-1500, and >2500 classes (F=39.61; df 1; p=0.0001; F=30.98; df 1; p=0.0001 and 
F=39.14; df 1; p=0.0001, respectively) without interaction between treatments. (D) Myofiber cross-sectional 
area distribution of TA muscles of mice without (-) or after rapamycin (Rapa) treatment, four weeks after 
denervation. Data are shown as mean ± SEM; n=4 mice per each condition. Two-way ANOVA revealed an 
effect of denervation in the 500-1500, 1000-1500 and >2500 classes (F=53.95; df 1; p=0.0001; F=14.23; df 
1; p=0.0054 and F=91.95; df 1; p=0.0001, respectively) without interaction between treatments. 
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not induce muscle atrophy in control muscles, neither 
enhanced muscle atrophy in denervated ones, indicating 
that autophagy does not induce nor exacerbate muscle 
fiber atrophy following denervation. In agreement with 
our study, inhibition of autophagy does not preserve 
skeletal muscle mass following denervation,25 indicating 
that autophagy activation is not required for denervation-
dependent muscle atrophy and rapamycin treatment. 
Moreover, rapamycin treatment has been already shown 
to do not exacerbate neurogenic muscle atrophy, or to 
induce muscle atrophy, after three weeks of 
denervation.45 Since skeletal muscle denervation induces 
a shift in fiber metabolism,50 being autophagy involved 
in the regulation of skeletal muscle metabolism,24,25 we 
speculate that autophagy activation could mediate the 
denervation-dependent metabolic changes in skeletal 
muscle. 
In conclusion, we monitored the activation of autophagy 
since the early phases following denervation, thus 
contributing new evidence to a model whereby 
neurogenic muscle atrophy and autophagic induction 
occurs despite Akt activation. Moreover, increased 
autophagy does not cause muscle fiber atrophy per se, 
nor it exacerbates muscle fiber atrophy in response to 
denervation, highlighting the importance of autophagy in 
regulating cellular responses other than muscle trophism. 
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